Export

Hydrocortisone
Essential medicine status
Section:
13. Dermatological medicines 13.3. Dermatological medicines > Anti-inflammatory and antipruritic medicines
ATC codes: D07AA02
EMLc
Indication
Psoriasis of unspecified type ICD11 code: EA90.Z
INN
Hydrocortisone
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Local > Topical > Cream: 1% (acetate)
Local > Topical > Ointment: 1% (acetate)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 2007 (TRS 950)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
EML: Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup:D07AA Corticosteroids, weak (group I).
Therapeutic alternatives limitations for EMLc
The square box does not apply for the listing of hydrocortisone on the EMLc.
Patent information
Patents have expired in most jurisdictions
Wikipedia
Hydrocortisone
DrugBank
Hydrocortisone
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that medicines in 4th level ATC chemical subgroup, D07AA Corticosteroids, weak (group I), be specified as therapeutic alternatives under the square box listing for hydrocortisone on the EML for this indication. The square box does not apply to the listing of hydrocortisone on the EMLc for this indication.